Please login to the form below

Not currently logged in
Email:
Password:

drug discovery

This page shows the latest drug discovery news and features for those working in and with pharma, biotech and healthcare.

AI specialist Exscientia buys Kinetic Discovery

AI specialist Exscientia buys Kinetic Discovery

AI specialist Exscientia buys Kinetic Discovery. The biophysics tech will radically improve the drug discovery paradigm, says Exscientia. ... Exscientia has bolstered its drug discovery platform by acquiring Kinetic Discovery in a deal that it says will

Latest news

More from news
Approximately 8 fully matching, plus 428 partially matching documents found.

Latest Intelligence

  • Made in China Made in China

    Meanwhile the national medicines regulator the Chinese Food and Drug Administration has also been reformed and renamed as the National Medical Products Administration of China (NMPA). ... complete with its own novel drug discovery and development

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    Operating mostly under the radar this service has yet to market itself widely but the potential to identify cost-effective and clinically successful drug regimes is enormous. ... The fact that innovation outside the core drug discovery business is

  • 30 Women Leaders in UK Healthcare (part 2)

    11. Jackie Hunter, CEO, BenevolentBio. Jackie Hunter is a hugely experienced drug discovery scientist who is now championing the use of AI to transform pharma R&D. ... In the meantime, she is challenging not just the accepted ways of conducting drug

  • 30 Women Leaders in UK Healthcare

    Dr Marshall is a world-leading expert in G-Protein-Coupled-Receptor (GPCR) biology and drug discovery. ... Noor Shaker believes her young start-up company GTN can revolutionise drug discovery through the application of artificial intelligence, and

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    This includes tackling one of the world’s biggest health problems today – the growing threat of drug resistant ‘superbugs’. ... tools for drug discovery and as direct therapies for currently untreatable conditions.

More from intelligence
Approximately 0 fully matching, plus 52 partially matching documents found.

Latest appointments

  • Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team

    He has had the opportunity to work across the full spectrum of the drug lifecycle, from discovery to patent expiry, and his operational and strategic experiences will be vital assets that

  • Industry round up: appointments Industry round up: appointments

    Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28 years’experience in clinical development and drug discovery. ... Concept Life Sciences appoints John Vu as

  • Concept Life Sciences adds to its team Concept Life Sciences adds to its team

    Integrated drug discovery, development and analytical services company Concept Life Sciences has appointed Matilda Bingham as site director of its Alderley Park unit based in Cheshire, UK. ... She said: “I am looking forward to applying my own drug

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson.

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Metrion Biosciences, the specialist ion channel contract research and drug discovery group, has appointed Dr Barry Kenny and Dr Andrew Southan to its board of directors, a move that will see ... Dr Kenny is currently chief business officer of Heptares

More from appointments
Approximately 0 fully matching, plus 71 partially matching documents found.

Latest from PMHub

  • Shantani Proteome Analytics Pvt. Ltd.

    Shantani Proteome Analytics Pvt. Ltd. Shantani's portfolio of services helps in identifying and validating drug targets of small molecules. ... It allows early de-risking of drug-discovery programs and supports crucial Go/No-Go decisions throughout the

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    References:. Qian X, et al. Nature Reviews Drug Discovery. 2015; 14:675-76.

  • Healthcare in the Digital Age

    Drug discovery is buoyant and innovative technology is pushing medicine forward at unprecedented speed. ... patients and physicians.Now in its tenth year, the Drug Discovery 2016 conference, being held in Liverpool, bristles with life-science promise and

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics